{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:32:51Z","timestamp":1787639571323,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EEQ\/2020\/000303"],"award-info":[{"award-number":["EEQ\/2020\/000303"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF190417"],"award-info":[{"award-number":["IF190417"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FIST\/CS-I\/2019\/120"],"award-info":[{"award-number":["SR\/FIST\/CS-I\/2019\/120"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011349","name":"University of Texas at El Paso","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015063","name":"National Institute of Technology Calicut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["628-166-2025"],"award-info":[{"award-number":["628-166-2025"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109783","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:47:16Z","timestamp":1773967636000},"page":"109783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as potent anticancer agents: Structure-based design, synthesis, mechanistic insights, target identification, and molecular docking studies"],"prefix":"10.1016","volume":"175","author":[{"given":"Neethu Mariam","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kallingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Maciejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munugala","family":"Chandrakanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun Thachan","family":"Kundil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Abhithaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Narajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Gondru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Healthina","family":"Pasangha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janardhan","family":"Banothu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2026.109783_bb0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioorg.2026.109783_bb0010","article-title":"The difficulties in cancer treatment","volume":"6","author":"Chakraborty","year":"2012","journal-title":"eCancerMedicalScience"},{"key":"10.1016\/j.bioorg.2026.109783_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anti-cancer activities: an overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109783_bb0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40199-019-00290-3","article-title":"Exploration of quinolone and quinoline derivatives as potential anticancer agents","volume":"27","author":"Iqbal","year":"2019","journal-title":"Daru"},{"issue":"16","key":"10.1016\/j.bioorg.2026.109783_bb0025","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.3390\/molecules26164899","article-title":"Design, synthesis, and anticancer activity studies of novel quinoline-chalcone derivatives","volume":"26","author":"Guan","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109783_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104168","article-title":"Review on recent development of quinoline for anticancer activities","volume":"15","author":"Ilakiyalakshmi","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2026.109783_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101432","article-title":"Quinone scaffolds as potential therapeutic anticancer agents: chemistry, mechanism of actions, structure-activity relationships and future perspectives","volume":"7","author":"Faizan","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2026.109783_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116674","article-title":"Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold","volume":"59","author":"Sharma","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109783_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010186","article-title":"Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II","volume":"5","author":"Hawtin","year":"2010","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109783_bb0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s001150050044","article-title":"Immune modulation in multiple sclerosis: linomide","volume":"67","author":"Weilbach","year":"1996","journal-title":"Nervenarzt"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109783_bb0055","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1212\/WNL.54.9.1726","article-title":"Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI analysis center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators","volume":"54","author":"Noseworthy","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109783_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.47.2.341","article-title":"Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation","volume":"47","author":"Karussis","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109783_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2011.02.021","article-title":"Laquinimod in multiple sclerosis","volume":"142","author":"Giacomini","year":"2012","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109783_bb0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.bjc.6605322","article-title":"Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer","volume":"101","author":"Bratt","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109783_bb0075","first-page":"167","article-title":"A review of tasquinimod in the treatment of advanced prostate cancer","volume":"21","author":"Williamson","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109783_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-013-2321-8","article-title":"Mechanisms of action of tasquinimod on the tumour microenvironment","volume":"73","author":"Raymond","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109783_bb0085","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s11094-023-02794-4","article-title":"Anticancer activity\u2013structure relationship of quinolinone-core compounds: an overall review","volume":"56","author":"Beker","year":"2023","journal-title":"Pharm. Chem. J."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109783_bb0090","article-title":"Ubiquitous nature of fluoroquinolones: the oscillation between antibacterial and anticancer activities","volume":"6","author":"Idowu","year":"2017","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bioorg.2026.109783_bb0095","article-title":"Insights on fluoroquinolones in cancer therapy: chemistry and recent developments","volume":"17","author":"Sharma","year":"2020","journal-title":"Mater. Today Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109783_bb0100","article-title":"Structural hybridization as a facile approach to new drug candidates","volume":"30","author":"Halmuthur","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109783_bb0105","article-title":"Coumarin\u2013benzimidazole hybrids: a review of developments in medicinal chemistry","volume":"227","author":"Arya","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109783_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137197","article-title":"Coumarin\u20131,2,4-triazole hybrids: recent advances in synthesis and medicinal applications","volume":"1299","author":"Chandrakanth","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109783_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129881","article-title":"Identification of coumarin \u2013 benzimidazole hybrids as potential antibacterial agents: synthesis, in vitro and in vivo biological assessment, and ADMET prediction","volume":"110","author":"Arya","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109783_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00513261","article-title":"Simple method for the preparation of 1-substituted isatins","volume":"19","author":"Radul","year":"1983","journal-title":"Chem. Heterocycl. Compd."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109783_bb0125","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.tetasy.2010.07.001","article-title":"Synthesis of N-alkylanthranilamides with a chiral substituent at the nitrogen atom","volume":"21","author":"Alexander","year":"2010","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.bioorg.2026.109783_bb0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109783_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-62703-577-4_14","article-title":"Bioassays for anticancer activities","volume":"1055","author":"McCauley","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109783_bb0140","first-page":"5","article-title":"Cell cycle deregulation: a common motif in cancer","volume":"5","author":"Malumbres","year":"2003","journal-title":"Prog. Cell Cycle Res."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109783_bb0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-6147(03)00026-9","article-title":"Cell-cycle dysregulation and anticancer therapy","volume":"24","author":"Stewart","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109783_bb0150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.18632\/aging.100284","article-title":"Recent developments in the use of \u03b3-H2AX as a quantitative DNA double-strand break biomarker","volume":"3","author":"Redon","year":"2011","journal-title":"Aging"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109783_bb0155","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.374","article-title":"Protocol for apoptosis assay by flow cytometry using Annexin V staining method","volume":"3","author":"Lakshmanan","year":"2013","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.bioorg.2026.109783_bb0160","article-title":"New frontiers in anti-cancer drug testing: the need for a relevant in vitro testing model","volume":"1","author":"Varshini","year":"2024","journal-title":"NAM J."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109783_bb0165","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio. Protoc."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109783_bb0170","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/ijms19071985","article-title":"Detection of the mitochondrial membrane potential by the cationic dye JC-1 in L1210 cells with massive overexpression of the plasma membrane ABCB1 drug transporter","volume":"19","author":"Elefantova","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109783_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137803","article-title":"Synthesis of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazoles as potent EGFR targeting anti-breast cancer agents","volume":"1306","author":"Chirra","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109783_bb0180","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1039\/D4NJ00824C","article-title":"Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines","volume":"48","author":"Fabitha","year":"2024","journal-title":"New J. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109783_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109783_bb0190","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modeling: towards prediction paradasie?","volume":"2","author":"Gifford","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109783_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drudis.2009.09.010","article-title":"Computational toxicology: a tool for early safety evaluation","volume":"15","author":"Merlot","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109783_bb0200","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jhet.4488","article-title":"Novel tryptanthrin hybrids bearing aminothiazoles as potential EGFR inhibitors: design, synthesis, biological screening, molecular docking studies, and ADME\/T predictions","volume":"59","author":"Palabindela","year":"2022","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.109783_bb0205","article-title":"An investigation into the use of computational and in vitro methods for acute systemic toxicity prediction","author":"Hedvig","year":"2012","journal-title":"European Commission Joint Research Centre, JRC Scientific and Policy Reports"},{"key":"10.1016\/j.bioorg.2026.109783_bb0210","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1021\/acs.jmedchem.2c01655","article-title":"Small-molecule modulators targeting toll-like receptors for potential anticancer therapeutics","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109783_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1021\/acs.jmedchem.0c01627","article-title":"TLR2 agonistic small molecules: detailed structure\u2013activity relationship, applications, and future prospects","volume":"64","author":"Kaur","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109783_bb0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acsmedchemlett.8b00540","article-title":"Identification of human toll-like receptor 2-agonistic activity in dihydropyridine\u2013quinolone carboxamides","volume":"10","author":"Hu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.109783_bb0225","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109783_bb0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"D1","key":"10.1016\/j.bioorg.2026.109783_bb0235","doi-asserted-by":"crossref","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","article-title":"OMIM.org: leveraging knowledge across phenotype-gene relationships","volume":"47","author":"Amberger","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2026.109783_bb0240","article-title":"Rational confederation of genes and diseases: NGS interpretation via GeneCards, MalaCards and VarElect","volume":"16","author":"Rappaport","year":"2017","journal-title":"Biomed. Eng. Online"},{"issue":"D1","key":"10.1016\/j.bioorg.2026.109783_bb0245","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109783_bb0250","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1039\/D5MD00161G","article-title":"Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations","volume":"16","author":"Fabitha","year":"2025","journal-title":"RSC Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:50:33Z","timestamp":1776109833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"alternative-id":["S0045206826003196"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109783","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as potent anticancer agents: Structure-based design, synthesis, mechanistic insights, target identification, and molecular docking studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109783"}}